Search

Background: Pancreatic ductal adenocarcinoma (PDAC) has a high recurrence rate even after curative resection. Lung recurrence may have better outcomes than other recurrences. However, its detailed clinicopathological features are unclear. We investigated the clinicopathological features and risk factors for lung recurrence after pancreatectomy for PDAC., Methods: The study included 161 patients with potentially and borderline resectable PDAC who had undergone R0 or R1 pancreatectomy between January 2008 and December 2016. We retrospectively examined the prognosis and predictors for lung recurrence after curative resection., Results: Seventeen patients (10.6%) had isolated lung recurrence. The median overall and recurrence-free survivals were 38.0 and 16.1 months, respectively. In multivariate analysis, para-aortic lymph node (PALN) metastasis (p = 0.006) and female sex (p = 0.027) were independent factors for lung recurrence., Conclusion: Lung recurrence had a better prognosis than other recurrences. PALN metastasis and female sex are independent risk factors for lung recurrence after curative resection for PDAC., Competing Interests: Declaration of competing interest The Authors declare no conflicts of interest., (Copyright © 2022 Asian Surgical Association and Taiwan Robotic Surgery Association. Published by Elsevier B.V. All rights reserved.)

Background: The present study aimed to assess the clinical features of patients who received lenvatinib treatment for unresectable hepatocellular carcinoma (HCC)., Methods: The clinical characteristics, adverse events, and radiological responses were evaluated for 51 consecutive patients., Results: Of the study subjects, 37 patients had Child-Pugh class A (CPA) liver function, and 14 patients had Child-Pugh class B (CPB) liver function. The overall response rates in the CPA and CPB groups were 42.9% and 25.0%, respectively, and disease control rates were 82.9% and 83.3%, respectively, without significant difference (p = 0.2621 and 0.9697). There was no significant difference between CPA and CPB groups regarding the incidence of adverse events, except for hepatic coma. No significant difference was observed in the relative dose intensity between the CPA and CPB groups, for the first month, 1-2 months, or 2-3 months (p = 0.2368, 0.9368, and 0.9293)., Conclusion: The comparable outcomes between the CPA and CPB groups suggest the acceptability of lenvatinib treatment in patients with impaired liver function, at least in the acute phase. With careful follow-up, the dose can be relatively intensified, even in patients with impaired liver function and this may contribute to offering comparable treatment., (Copyright © 2020 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.)

From research on PM(2.5) and PM(10) in 2007/2008 in the Netherlands, it was concluded that the coarse fraction (PM(2.5-10)) attributed 60% and 50% respectively, to the urban-regional and street-urban increments of PM(10). Contrary to Scandinavian and Mediterranean countries which exhibit significant seasonal variation in the coarse fraction of particulate matter (PM), in the Netherlands the coarse fraction in PM at a street location is rather constant during the year. Non-exhaust emissions by road traffic are identified as the main source for coarse PM in urban areas. Non-exhaust emissions mainly originate from re-suspension of accumulated deposited PM and road wear related particles, while primary tire and brake wear hardly contribute to the mass of non-exhaust emissions. However, tire and brake wear can clearly be identified in the total mass through the presence of the heavy metals: zinc, a tracer for tire wear and copper, a tracer for brake wear. The efficiency of road sweeping and washing to reduce non-exhaust emissions in a street-canyon in Amsterdam was investigated. The increments of the coarse fraction at a kerbside location and a housing façade location versus the urban background were measured at days with and without sweeping and washing. It was concluded that this measure did not significantly reduce non-exhaust emissions., (Copyright 2010 Elsevier B.V. All rights reserved.)

Large-scale use of leaded gasoline was an important source of the neurotoxin lead in the European environment. After a sequence of regulations on the allowed gasoline lead content and, eventually, a ban on the use of lead additives in gasoline, road transport was no longer considered a source of atmospheric lead. Currently a discrepancy exists between measured atmospheric lead concentrations and model-predicted concentrations, suggesting that lead emissions to the atmosphere may be underestimated. Recently it was suggested that lead emission from unleaded gasoline combustion is still an important source and may (partly) fill the gap between modelled and observed atmospheric lead concentrations. In this paper we assess the plausibility of the latter suggestion by following various emission estimation methodologies. The uncertainty of lead emissions from road transport is further reduced by chemical analysis of fuel samples. The result of our assessment is that lead from road transport fuel combustion is not the missing lead source needed to fill the gap between modelled and observed lead concentrations. Road transport is still a source of lead through brake wear and a small contribution from exhaust emissions but this contributes no more than 5-8% of the EU25 total emission.